M O 5 (Oxybutynin chloride extended release 5 mg)

Pill imprint M O 5 has been identified as Oxybutynin chloride extended release 5 mg.

Oxybutynin is used in the treatment of overactive bladder; urinary incontinence; hyperhidrosis; dysuria; prostatitis and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 5 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for M O 5 (Oxybutynin chloride extended release 5 mg)

Oxybutynin chloride extended release 5 mg M O 5
Oxybutynin chloride extended release 5 mg M O 5  Front
Oxybutynin chloride extended release 5 mg M O 5  Back
Oxybutynin chloride extended release 5 mg M O 5
Oxybutynin chloride extended release
Imprint:
M O 5
Strength:
5 mg
Color:
Green
Size:
8.00 mm
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
Urinary antispasmodics
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-6605
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0722 UDL Laboratories Inc
16590-0321 Stat RX USA LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web1)